+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

LAMEA Cell-based Assays Market Size, Share & Industry Trends Analysis Report by Application (Drug Discovery, Basic Research and Others), End-user, Products & Services, Country and Growth Forecast, 2022-2028

  • PDF Icon

    Report

  • 87 Pages
  • October 2022
  • Region: Africa, Middle East
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
  • ID: 5694755
The Latin America, Middle East and Africa Cell-based Assays Market should witness market growth of 11.4% CAGR during the forecast period (2022-2028).

HCS enables the automated detection of modifiers of accessible as well as biologically relevant targets. As a result, it can be used to detect gene interactions or find hazardous pathways of drug candidates, both of which are useful in improving the processes of drug discovery and development. These assays include immunohistochemistry, reporter gene assay, RNAi, CRISPR-Cas9 system, and protein-protein interactions.

These assays are used to evaluate a wide range of cellular processes, such as protein expression, proliferation, morphological changes, localization, post-translational modifications, as well as protein-protein interactions. These cell-based assay techniques can be applied to both 2D and 3D cell culture systems in a high-throughput way. Additionally, these methods can be used with either primary or secondary cultures.

In recent years, there has been a significant increase in demand for cell-based assays. This can be attributed to the rise in cell-based applications in drug development as well as the technological breakthroughs that have been made in the methodologies used for cell-based assays. The rise in the prevalence of lifestyle disorders, like arthritis, cancer, diabetes, epilepsy, cardiovascular diseases, and many others, which still have considerable unmet requirements and have prompted continuous expenditures in R&D, is another significant driver that drives market expansion.

This market is also being pushed by a growth in the use of cell-based assay methodologies for high throughput screening procedures, such as toxicity research, in-vitro testing, drug screening, and a variety of other types of testing, among other things. The use of high-throughput screening technologies and an increase in spending on research and development are both contributing factors that are driving the market.

The stem cell is an emerging field of research in South Africa, with a number of public as well as private research institutes shifting their focus toward the sector. Both communicable diseases (infectious diseases, such as Tuberculosis/TB), as well as non-communicable diseases, are being researched by the Stem Cell Research and Therapy Unit in South Africa in an effort to find strategies to reduce the country's overall infection incidence. Both the law and ethical considerations must be taken into account prior to and during the process of using stem cells in medical research and treatment protocols. In this aspect, the law and medical ethics go hand in hand with each other.

The Brazil market dominated the LAMEA Cell-based Assays Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $413.9 Million by 2028, growing at a CAGR of 10.3 % during the forecast period. The Argentina market is showcasing a CAGR of 12% during (2022-2028). Additionally, The UAE market would register a CAGR of 11.1% during (2022-2028).

Based on Application, the market is segmented into Drug Discovery, Basic Research and Others. Based on End-user, the market is segmented into Pharmaceutical & Biotechnology Companies, Academic & Research Institutes and Contract Research Organizations (CROs). Based on Products & Services, the market is segmented into Assay Kits, Reagents, Microplates, Probes & Labels, Instruments & Software and Cell Lines. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.0

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Corning Incorporated, Charles River Laboratories International, Inc., Danaher Corporation, F. Hoffmann-La Roche Ltd., Lonza Group AG, Merck Group, Promega Corporation and Thermo Fisher Scientific, Inc.

Scope of the Study

By Application

  • Drug Discovery
  • Basic Research
  • Others

By End-user

  • Pharmaceutical & Biotechnology Companies
  • Academic & Research Institutes
  • Contract Research Organizations (CROs)

By Products & Services

  • Assay Kits
  • Reagents
  • Microplates
  • Probes & Labels
  • Instruments & Software
  • Cell Lines

By Country

  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Key Market Players

List of Companies Profiled in the Report:

  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Corning Incorporated
  • Charles River Laboratories International, Inc.
  • Danaher Corporation
  • F. Hoffmann-La Roche Ltd.
  • Lonza Group AG
  • Merck Group
  • Promega Corporation
  • Thermo Fisher Scientific, Inc.

Unique Offerings

  • Exhaustive coverage
  • The highest number of Market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Cell-based Assays Market, by Application
1.4.2 LAMEA Cell-based Assays Market, by End-user
1.4.3 LAMEA Cell-based Assays Market, by Products & Services
1.4.4 LAMEA Cell-based Assays Market, by Country
1.5 Research Methodology
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 The Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.2.4 Geographical Expansions
3.2.5 Approvals and Trials
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)
3.3.2 Key Strategic Move: (Product Launches and Product Expansions : 2018, Jun - 2021, Jun) Leading Players
Chapter 4. LAMEA Cell-based Assays Market by Application
4.1 LAMEA Drug Discovery Market by Country
4.2 LAMEA Basic Research Market by Country
4.3 LAMEA Others Market by Country
Chapter 5. LAMEA Cell-based Assays Market by End-use
5.1 LAMEA Pharmaceutical & Biotechnology Companies Market by Country
5.2 LAMEA Academic & Research Institutes Market by Country
5.3 LAMEA Contract Research Organizations (CROs) Market by Country
Chapter 6. LAMEA Cell-based Assays Market by Products & Services
6.1 LAMEA Assay Kits Market by Country
6.2 LAMEA Reagents Market by Country
6.3 LAMEA Microplates Market by Country
6.4 LAMEA Probes & Labels Market by Country
6.5 LAMEA Instruments & Software Market by Country
6.6 LAMEA Cell Lines Market by Country
Chapter 7. LAMEA Cell-based Assays Market by Country
7.1 Brazil Cell-based Assays Market
7.1.1 Brazil Cell-based Assays Market by Application
7.1.2 Brazil Cell-based Assays Market by End-use
7.1.3 Brazil Cell-based Assays Market by Products & Services
7.2 Argentina Cell-based Assays Market
7.2.1 Argentina Cell-based Assays Market by Application
7.2.2 Argentina Cell-based Assays Market by End-use
7.2.3 Argentina Cell-based Assays Market by Products & Services
7.3 UAE Cell-based Assays Market
7.3.1 UAE Cell-based Assays Market by Application
7.3.2 UAE Cell-based Assays Market by End-use
7.3.3 UAE Cell-based Assays Market by Products & Services
7.4 Saudi Arabia Cell-based Assays Market
7.4.1 Saudi Arabia Cell-based Assays Market by Application
7.4.2 Saudi Arabia Cell-based Assays Market by End-use
7.4.3 Saudi Arabia Cell-based Assays Market by Products & Services
7.5 South Africa Cell-based Assays Market
7.5.1 South Africa Cell-based Assays Market by Application
7.5.2 South Africa Cell-based Assays Market by End-use
7.5.3 South Africa Cell-based Assays Market by Products & Services
7.6 Nigeria Cell-based Assays Market
7.6.1 Nigeria Cell-based Assays Market by Application
7.6.2 Nigeria Cell-based Assays Market by End-use
7.6.3 Nigeria Cell-based Assays Market by Products & Services
7.7 Rest of LAMEA Cell-based Assays Market
7.7.1 Rest of LAMEA Cell-based Assays Market by Application
7.7.2 Rest of LAMEA Cell-based Assays Market by End-use
7.7.3 Rest of LAMEA Cell-based Assays Market by Products & Services
Chapter 8. Company Profiles
8.1 Becton, Dickinson and Company
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expense
8.1.5 Recent Strategies and Developments
8.1.5.1 Partnerships, Collaborations, and Agreements
8.1.5.2 Product Launches and Product Expansions
8.1.5.3 Acquisition and Mergers
8.2 F. Hoffmann-La Roche Ltd.
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expense
8.2.5 Recent Strategies and Developments
8.2.5.1 Partnerships, Collaborations, and Agreements
8.2.5.2 Product Launches and Product Expansions
8.2.5.3 Acquisition and Mergers
8.2.5.4 Approvals and Trials
8.3 Thermo Fisher Scientific, Inc.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expense
8.3.5 Recent Strategies and Developments
8.3.5.1 Partnerships, Collaborations, and Agreements
8.3.5.2 Geographical Expansions
8.4 Bio-Rad laboratories, Inc.
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expenses
8.4.5 Recent Strategies and Developments
8.4.5.1 Partnerships, Collaborations, and Agreements
8.4.5.2 Acquisition and Mergers
8.5 Charles River Laboratories International, Inc.
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Recent Strategies and Developments
8.5.4.1 Partnerships, Collaborations, and Agreements
8.5.4.2 Acquisition and Mergers
8.6 Danaher Corporation
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.6.4 Research & Development Expense
8.6.5 Recent Strategies and Developments
8.6.5.1 Product Launches and Product Expansions
8.7 Merck Group
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental and Regional Analysis
8.7.4 Research & Development Expense
8.7.5 Recent Strategies and Developments
8.7.5.1 Partnerships, Collaborations, and Agreements
8.8 Lonza Group AG
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental and Regional Analysis
8.8.4 Research & Development Expenses
8.8.5 Recent Strategies and Developments
8.8.5.1 Partnerships, Collaborations, and Agreements
8.9 Corning Incorporated
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Segmental and Regional Analysis
8.9.4 Research & Development Expenses
8.9.5 Recent Strategies and Developments
8.9.5.1 Product Launches and Product Expansions
8.10. Promega Corporation
8.10.1 Company Overview
8.10.2 Recent Strategies and Developments
8.10.2.1 Partnerships, Collaborations, and Agreements
8.10.2.2 Product Launches and Product Expansions

Companies Mentioned

  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Corning Incorporated
  • Charles River Laboratories International, Inc.
  • Danaher Corporation
  • F. Hoffmann-La Roche Ltd.
  • Lonza Group AG
  • Merck Group
  • Promega Corporation
  • Thermo Fisher Scientific, Inc.

Methodology

Loading
LOADING...